Showing results (21-30 of 109) with videos related to
Sort By:
Pageof 11
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 27, 2005
Augmenting T helper cell immunity in cancerK L Knutson, M L DisisCancer Immunology, Immunotherapy : CII|July 13, 2005
Tumor antigen-specific T helper cells in cancer immunity and immunotherapyK L Knutson, M L DisisImmunobiology|June 2, 2000
Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expressionH Bernhard, E S Huseby, S L Hand, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1994
Donor T cells can be induced to grow and survive long term in vivo without previous host immunosuppressionW Chen, M A CheeverImmunological Reviews|June 1, 1997
Therapy with cultured T cells: principles revisitedM A Cheever, W ChenThe Journal of Clinical Investigation|February 22, 2001
Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patientsK L Knutson, K Schiffman, M L DisisClinical Lung Cancer|January 22, 2004
Cancer vaccines for the treatment and prevention of non small-cell lung cancerM L Disis, H L West, K SchiffmanJournal of Biological Response Modifiers|October 1, 1984
Effector mechanisms operative in adoptive therapy of tumor-bearing animals: implications for the use of interleukin-2P D Greenberg, M A CheeverJournal of Immunology (Baltimore, Md. : 1950)|December 1, 1984
Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cellsP D Greenberg, M A CheeverPageof 11